Sartorius Group AG has acquired instrument maker Essen BioScience Inc. from SFW Capital Partners for $320 million. SFW made an investment in the target in 2014.

Essen, based in Ann Arbor, Michigan and founded in 1996, develops instruments and software for life sciences under the IncuCyte system. IncuCyte monitors real time cellular behavior by gathering images for researchers. The target expects to generate around $60 million in sales in 2017.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.